BI671800 in Asthmatic Patients on Inhaled Corticosteroids
| Status: | Archived |
|---|---|
| Conditions: | Asthma |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2010 |
Randomised, Double Blind, Double Dummy, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of 6 Weeks of Oral BI 671800 ED Twice Daily (b.i.d.), Montelukast Once Daily (q.d.) or Placebo in Symptomatic Asthmatic Patients on Low Dose Fluticasone Propionate MDI (Metered Dose Inhaler)
This is a 6 week study to assess the effect of BI 671800 in patients with asthma. It is a
double blind, parallel arm trial testing the safety and efficacy of BI 671800. The main
objective is to assess the effect on lung function. The study will also provide data on the
pharmacokinetics of BI 671800.
We found this trial at
4
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials